Ceftivo S 250mg/125mg Injection
Marketer
Invomed Cotab Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Ceftivo S 250mg/125mg Injection
Ceftivo S 250mg/125mg Injection, a dual-action antibiotic, combats various bacterial infections by inhibiting microbial growth and propagation. This medication requires administration by a healthcare professional; adherence to the prescribed dosage schedule is crucial. Complete the entire treatment course, even with symptom improvement, as premature cessation can compromise its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing somnolence or vertigo. Adequate rest, a balanced diet, and sufficient hydration will facilitate recovery. Your physician may order laboratory tests to monitor therapeutic response.
Uses of Ceftivo S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Ceftivo S 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ceftivo S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ceftivo S 250mg/125mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Ceftivo S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Ceftivo S 250mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, inhibiting their growth and survival. The addition of Sulbactam, a beta-lactamase inhibitor, counteracts bacterial defenses, optimizing Ceftriaxone's efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Ceftivo S 250mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Ceftivo S (250mg/125mg) is typically deemed safe for pregnant individuals. Preclinical trials using animals have revealed minimal to no negative consequences for fetal development; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Ceftivo S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ceftivo S 250mg/125mg Injection might cause drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Ceftivo S 250mg/125mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The injectable medication Ceftivo S (250mg/125mg) requires careful administration for individuals with severe hepatic impairment; dosage modification may be necessary. Seek medical advice. Dosage changes for Ceftivo S (250mg/125mg) injection are unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ceftivo S 250mg/125mg Injection :
Should you inadvertently skip a dose of Ceftivo S 250mg/125mg Injection, seek medical advice.
Facts to Know About Ceftivo S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently